The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized treatment outcomes in never smokers with advanced non-small cell lung cancer (NSCLC) in the Princess Margaret Cancer Centre.
 
Grzegorz Korpanty
No Relationships to Disclose
 
Suzanne Kamel-Reid
No Relationships to Disclose
 
Ming Sound Tsao
Honoraria - AstraZeneca; Novartis; Pfizer; Precision Therapeutics; Roche/Genentech
Speakers' Bureau - Boehringer Ingelheim; Pfizer
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Prognostic gene signature for early stage non-small cell lung cancer
 
David M Hwang
Honoraria - Pfizer
 
Alona Zer
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - novartis; pfizer
Consulting or Advisory Role - novartis; pfizer
Research Funding - roche (Inst)
 
Natasha B. Leighl
Research Funding - Roche Canada (Inst)
 
Ronald Feld
No Relationships to Disclose
 
Bethany Gill
No Relationships to Disclose
 
Melania Pintilie
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lilly
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Novartis